Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;52(6):688-96.
doi: 10.1007/s00108-010-2769-0.

[Managing comorbidities of inflammatory rheumatic diseases]

[Article in German]
Affiliations

[Managing comorbidities of inflammatory rheumatic diseases]

[Article in German]
K de Groot et al. Internist (Berl). 2011 Jun.

Abstract

Patients with inflammatory rheumatic diseases often suffer from considerable comorbidities that can arise due to the chronic systemic inflammatory activity of the rheumatic disease itself, disorders of immune defense, or as a result of antirheumatic treatment; they can also occur independently. For example, almost 50% of patients with rheumatoid arthritis already exhibit two further chronic diseases at the time of initial manifestation. With regard to the elevated mortality observed in patients with rheumatism, particularly cardiovascular morbidity and increased predisposition to infections are of note. In addition, this article addresses further important possible concomitant diseases, i.e., osteoporosis and tumor diseases. A ground rule is to identify comorbidities and treat them just as diligently as the underlying rheumatic disease so that the patient with rheumatism should be accompanied by an interdisciplinary team of internists during each phase of the disease. Effective control of the systemic inflammatory activity may serve to reduce the risk of certain cardiovascular and neoplastic comorbidities.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 2005 Jan 27;352(4):351-61 - PubMed
    1. Ann Rheum Dis. 2010 Mar;69(3):579-81 - PubMed
    1. J Rheumatol. 2008 Jan;35(1):100-5 - PubMed
    1. Z Rheumatol. 2006 Oct;65(6):487-8, 490-4, 496 - PubMed
    1. Med Oncol. 2009;26(1):1-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources